HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

CF101

A3 adenosine receptor agonist; structure in first source
Also Known As:
1-deoxy-1-(6-(((iodophenyl)methyl)amino)9H-purine-9-yl)-N-methyl-(D-ribofuranuronamide); CF-101
Networked: 17 relevant articles (4 outcomes, 9 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Fishman, Pnina: 9 articles (06/2013 - 04/2004)
2. Bar-Yehuda, Sara: 7 articles (06/2013 - 04/2004)
3. Fishman, P: 6 articles (03/2012 - 10/2003)
4. Ochaion, Avivit: 6 articles (11/2011 - 04/2004)
5. Bar-Yehuda, S: 5 articles (09/2011 - 10/2003)
6. Cohen, Shira: 4 articles (06/2013 - 10/2007)
7. Madi, Lea: 4 articles (01/2006 - 04/2004)
8. Rath-Wolfson, L: 3 articles (09/2011 - 10/2003)
9. Farbstein, Motti: 3 articles (07/2010 - 01/2006)
10. Silverman, Michael H: 3 articles (07/2010 - 10/2007)

Related Diseases

1. Dry Eye Syndromes (Dry Eye Syndrome)
2. Uveitis
3. Psoriasis (Pustulosis Palmaris et Plantaris)
4. Glaucoma
5. Rheumatoid Arthritis

Related Drugs and Biologics

1. Purinergic P1 Receptors (Adenosine Receptor)
2. Retinaldehyde (Retinal)
3. Antigens
4. preladenant
5. N-(3-tetrahydrofuranyl)-6-aminopurine riboside
6. 2- (cyclohexylmethylidenehydrazino)adenosine
7. interstitial retinol-binding protein
8. Caspase 3 (Caspase-3)
9. Cyclin D1
10. NF-kappa B (NF-kB)

Related Therapies and Procedures

1. Oral Administration
2. Heterologous Transplantation (Xenotransplantation)
3. Therapeutics